Business Context and Reporting Period
This Form 8-K was filed by Keros Therapeutics, Inc. on March 2, 2021. The report serves as a current disclosure under Regulation FD regarding an upcoming corporate presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a scheduled event and does not contain financial statements or operational metrics.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a future event.
Guidance, Outlook, and Management Commentary
- Upcoming Presentation: Jasbir Seehra, President and Chief Executive Officer, is scheduled to present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference on Tuesday, March 9, 2021.
- Legal Status: The information furnished in this report and the accompanying press release (Exhibit 99.1) is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the H.C. Wainwright Global Life Sciences 2021 Virtual Conference presentation.
- Review the attached press release (Exhibit 99.1) for specific details on the presentation agenda.
- Check subsequent filings for any financial data or strategic updates disclosed during the March 9 presentation.